BOBBY MAYNOR: Open Payments
NPI 1043255219 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$944 in 52 payments from 22 companies in 2025. Trend: 2023 $282 · 2024 $1,125 · 2025 $944
Food & beverage: $944
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $172 |
| ABBVIE INC. | 6 | $126 |
| Amgen Inc. | 7 | $98 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $90 |
| Lilly USA, LLC | 3 | $50 |
| Phathom Pharmaceuticals, Inc. | 2 | $49 |
| PFIZER INC. | 3 | $45 |
| Astellas Pharma US Inc | 2 | $42 |
| Insmed, Inc. | 1 | $26 |
| Seqirus USA Inc | 1 | $25 |
Products named: JARDIANCE, QULIPTA, OTEZLA, Rybelsus, Ozempic, Wegovy, VOQUEZNA, ELIQUIS.
Industry payments across NC — which companies pay providers there.
